Grodzinski et al., 2006 - Google Patents
Nanotechnology for cancer diagnostics: promises and challengesGrodzinski et al., 2006
- Document ID
- 11623747742374125656
- Author
- Grodzinski P
- Silver M
- Molnar L
- Publication year
- Publication venue
- Expert review of molecular diagnostics
External Links
Snippet
Despite recent progress in the treatment of cancer, the majority of cases are still diagnosed only after tumors have metastasized, leaving the patient with a grim prognosis. However, there may be an opportunity to drastically reduce the burden of cancer, if the disease can be …
- 201000011510 cancer 0 title abstract description 85
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANO-TECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE OR TREATMENT OF NANO-STRUCTURES
- B82Y5/00—Nano-biotechnology or nano-medicine, e.g. protein engineering or drug delivery
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANO-TECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE OR TREATMENT OF NANO-STRUCTURES
- B82Y10/00—Nano-technology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Grodzinski et al. | Nanotechnology for cancer diagnostics: promises and challenges | |
| Leary et al. | Toward the emergence of nanoneurosurgery: Part II—Nanomedicine: Diagnostics and imaging at the nanoscale level | |
| Alrushaid et al. | Nanotechnology in cancer diagnosis and treatment | |
| Laroui et al. | Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders | |
| Hosu et al. | Implication of magnetic nanoparticles in cancer detection, screening and treatment | |
| Wang et al. | Nucleic acid conjugated nanomaterials for enhanced molecular recognition | |
| Jain | Applications of nanobiotechnology in clinical diagnostics | |
| Chan | Bionanotechnology progress and advances | |
| Nie et al. | Nanotechnology applications in cancer | |
| Ferrari | Cancer nanotechnology: opportunities and challenges | |
| Kawasaki et al. | Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer | |
| Yao et al. | Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy | |
| Salvati et al. | Nanosensors for early cancer detection and for therapeutic drug monitoring | |
| Sengupta et al. | Exploiting nanotechnology to target cancer | |
| Hu et al. | Nanodevices in diagnostics | |
| Jacob et al. | Nanoparticles and nanosized structures in diagnostics and therapy | |
| Jain | Nanomolecular diagnostics | |
| Tawade et al. | Nanotechnology in biological science and engineering | |
| Zuo et al. | New technology and clinical applications of nanomedicine | |
| Ltaief et al. | Recent developments in cancer diagnosis and treatment using nanotechnology | |
| Jain | Nanobiotechnology and personalized medicine | |
| Wang et al. | Trimodal Multiplexed Lateral Flow Test Strips Assisted with a Portable Microfluidic Centrifugation Device | |
| Jain | Role of nanodiagnostics in personalized cancer therapy | |
| Sharma | Next-Generation Nanomaterials for BiomedicalDevices: Advancements in Drug Delivery andDiagnostic Systems | |
| Sun et al. | Advances in the application of nanotechnology in the diagnosis and treatment of gastrointestinal tumors |